InsidersTradesSigma
Discover the complete record of transactions filed by Bjarke Henric Bjorn, Chief Executive Officer. Insider active across 1 company, notably Inozyme Pharma, Inc.. Cumulatively, 1 disclosures have been logged. Breakdown: 1 buy · 0 sell. Total volume traded: €93k. History available since 19 April 2022. The latest transaction was filed on 19 April 2022 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
1 of 1 declaration
Henric Bjorn Bjarke is the SVP and COO at Inozyme Pharma, Inc. He is responsible for overseeing the company's operations, ensuring efficiency and process optimization. His experience in the industry enables him to lead strategic initiatives to enhance operational performance.